Home
Issues
Aim & Scope
Open Access
Editorial Board
Indexing
Why publish with us
Contact us
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Special publications & Reprints
Authorship & COI
Principles of Transparency Checklist
Data Policies
Publication Ethics and Publication Malpractice Statement
CrossMark
Supporting Diversity
CONFERENCE PROCEEDING
Characterization of tobacco use among people who start a substance use treatment for alcohol and/or cannabis: ACT_ACT study
Cristina Martínez
1,2,3,4,10
1
Catalan Institute of Oncology, L’Hospitalet de Llobregat, Barcelona, Spain
2
Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
3
CIBER en Enfermedades Respiratorias, Madrid, Spain
4
Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
5
Addictive Behaviors Unit, Psychiatry Department, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain
6
Institute of Neuropsychiatry and Addictions, Institut Mar d’Investigacions Mèdiques, Consorci Mar Parc de Salut, Barcelona, Spain
7
Addictions Unit, Psychiatry Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
8
Mental Health Department, Althaia Xarxa Assistencial Universitària, Manresa, Barcelona, Spain
9
Pol Bruguera, Anna Alonso, Monika Anduaga, Sílvia Martínez, Beth Pallejà, Rosanna Reyes, Clara Caterina, Núria Cabezón, Carolina Franco, Delia Parellada, Laura Masferrer, Esther Batllori, Claudio Castillo and Maria Robles
10
Institute for Health Policy Studies, University of California San Francisco, San Francisco, United States of America
Publication date: 2023-04-25
Corresponding author
Tob. Prev. Cessation 2023;9(Supplement):A151
KEYWORDS
ABSTRACT
Introduction:
While the prevalence of tobacco use is fairly significant among people in treatment for substance abuse, its pattern has not been well described in Spain. The objective of this work is to characterize the pattern of tobacco use among people who start treatment for alcohol and/or cannabis use disorder in Substance Abuse Programs (SAP).
Material and Methods:
We conducted a cross-sectional analysis of the baseline ACT_ATAC study. This is a follow-up study carried out among people who started a therapeutic process for alcohol and/or cannabis use in 12 SAPs in Catalonia. Recruitment was carried out between November 2020 and December 2022. All the participants (N=126) were adults, smokers, enrolled in a therapeutical treatment for alcohol and/or cannabis use disorder, and had a telephone to be followed up.
Results:
126 individuals agreed to participate (67% men and 33% women). 63% of participants were alcohol users, 33% were cannabis users and 4% were dual users. People with alcohol use were on average 13 years older than those with cannabis use (49y vs. 36 y; p<0.01). 96% of the sample had used tobacco in the last 7 days prior to the interview. 67% of participants had a moderate-high nicotine dependence and the average motivation to quit was 6.4 out of 10. By type of substance, 59% of participants with an alcohol use used manufactured cigarettes while for cannabis users 39% did (p=0.053); and 34% of alcohol users consumed roll-your-own cigarettes (RYO) versus 43% of cannabis users (p=0.398). All cannabis smokers reported that they mixed cannabis with tobacco and most of them had more tobacco than cannabis in the joint.
Conclusions:
People with substance use disorder is more likely to consume RYO use than general population. It is necessary to develop specific motivational and therapeutic strategies to encourage smoking cessation in people undergoing treatment for other substances due to their moderate-high dependence and moderate motivation.
The ACT-ATAC Project is registered with Clinicaltrials.gov [NCT04841655].
While the prevalence of tobacco use is fairly significant among people in treatment for substance abuse, its pattern has not been well described in Spain. The objective of this work is to characterize the pattern of tobacco use among people who start treatment for alcohol and/or cannabis use disorder in Substance Abuse Programs (SAP).
Material and Methods:
We conducted a cross-sectional analysis of the baseline ACT_ATAC study. This is a follow-up study carried out among people who started a therapeutic process for alcohol and/or cannabis use in 12 SAPs in Catalonia. Recruitment was carried out between November 2020 and December 2022. All the participants (N=126) were adults, smokers, enrolled in a therapeutical treatment for alcohol and/or cannabis use disorder, and had a telephone to be followed up.
Results:
126 individuals agreed to participate (67% men and 33% women). 63% of participants were alcohol users, 33% were cannabis users and 4% were dual users. People with alcohol use were on average 13 years older than those with cannabis use (49y vs. 36 y; p<0.01). 96% of the sample had used tobacco in the last 7 days prior to the interview. 67% of participants had a moderate-high nicotine dependence and the average motivation to quit was 6.4 out of 10. By type of substance, 59% of participants with an alcohol use used manufactured cigarettes while for cannabis users 39% did (p=0.053); and 34% of alcohol users consumed roll-your-own cigarettes (RYO) versus 43% of cannabis users (p=0.398). All cannabis smokers reported that they mixed cannabis with tobacco and most of them had more tobacco than cannabis in the joint.
Conclusions:
People with substance use disorder is more likely to consume RYO use than general population. It is necessary to develop specific motivational and therapeutic strategies to encourage smoking cessation in people undergoing treatment for other substances due to their moderate-high dependence and moderate motivation.
The ACT-ATAC Project is registered with Clinicaltrials.gov [NCT04841655].
CONFLICTS OF INTEREST
The authors have no conflicts of interest to declare.
FUNDING
The ACT-ATAC study is partially funded by the Instituto de Salud Carlos III
(Grant: PI18/01420, co-funded by European Regional Development Fund ERDF, a way to build Europe) and the Canadian Institutes of Health Research (Foundation grant FDN- 148477). JS, ME, EF, and CM are partly supported by the Ministry of Universities and Research, Government of Catalonia (2021SGR00906).
Share
RELATED ARTICLE
| eISSN: | 2459-3087 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
